NUFORMIX
SHARE PRICE
0.265
CHANGE
0.055 ( 26.19%)
TICKER
NFX.L
Share Chart
Latest Articles for NFX.L
IN BRIEF: Nuformix raises GBP228,000 in open offer
Nuformix PLC - London-based developer of treatments for fibrosis and oncology - Raises approximately GBP228,081 through an underwritten open offer at an issue price of 0.2 pence per share. Valid...
TRADING UPDATES: Celsius raises funds; Built Cybernetics acquisition
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:...
IN BRIEF: Nuformix submits FDA drug designation application for NXP002
Nuformix PLC - London-based developer of treatments for fibrosis and oncology - Submits US Food & Drug Administration orphan drug designation application for the NXP002 programme in idiopathic pulmonary fibrosis....
Nuformix shares fall despite EU orphan drug status for lead treatment
(Alliance News) - Nuformix PLC on Thursday said its lead programme, NXP002, has been granted orphan drug designation by the European Medicines Agency for the treatment of idiopathic pulmonary fibrosis....